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Quantitative Computed Tomography Analysis, Airflow
Obstruction, and Lung Cancer in the Pittsburgh Lung
Screening Study
David O. Wilson, MD, MPH,* Joseph K. Leader, PhD,† Carl R. Fuhrman, MD,† John J. Reilly, MD,*
Frank C. Sciurba, MD,* and Joel L. Weissfeld, MD‡
Background: To study the relationship between emphysema, air-
flow obstruction, and lung cancer in a high-risk population, we
performed quantitative analysis of screening computed tomography
(CT) scans.
Methods: Subjects completed questionnaires, spirometry, and low-
dose helical chest CT. Analyses compared cases and controls ac-
cording to automated quantitative analysis of lung parenchyma and
airways measures.
Results: Our case-control study of 117 matched pairs of lung cancer
cases and controls did not reveal any airway or lung parenchymal
findings on quantitative analysis of screening CT scans that were
associated with increased lung cancer risk. Airway measures includ-
ing wall area %, lumen perimeter, lumen area and average wall
Hounsfield unit, and parenchymal measures including lung fraction
less than 910 Hounsfield units were not statistically different
between cases and controls.
Conclusions: The relationship between visual assessment of em-
physema and increased lung cancer risk could not be verified by
quantitative analysis of low-dose screening CT scans in a high-risk
tobacco exposed population.
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There is an association between airflow obstruction onspirometry and anatomic emphysema by visual assess-
ment on low-dose screening computed tomography (CT) scan
and lung cancer, as reported by us1 and others.2–7 Two reports
from the Mayo Clinic lung cancer screening study with small
numbers of lung cancers (n  24 and n  64, respectively)
used quantitative CT analysis to determine % emphysema
and concluded that the quantity of radiographic emphysema
was not found to be a significant risk for lung cancer.8,9 We
report on 117 pairs of subjects with lung cancer and matched
controls from the Pittsburgh Lung Screening Study (PLuSS)
analyzed by quantitative CT analysis for airway and paren-
chymal abnormalities. This is the first study to correlate
quantitative CT measures of parenchymal disease (lung frac-
tion 910 Hounsfield unit [HU]) with visual emphysema,
measures of airways disease (wall area and lumen measures)




The PLuSS involved 3642 subjects10 and was approved
by the Institutional Review Board of the University of Pitts-
burgh (approval no. 011171). Written informed consent was
obtained from all participants. Between January 2002 and
April 2005, volunteers with the following characteristics
were recruited: (1) age 50 to 79 years; (2) no personal lung
cancer history; (3) no participation in concurrent lung cancer
screening studies; (4) no chest CT within 12 months; (5)
current or excigarette smoker of at least one-half pack per
day for at least 25 years, and, if quit, quit for no more than
10 years before study enrollment; and (6) body weight less
than 400 pounds. Individuals were not excluded because of
symptoms.
PLuSS participants performed the following baseline
activities (T0) between March 2002 and September 2005: (1)
completed a risk factor questionnaire, (2) provided peripheral
blood samples, (3) underwent forced expiratory spirometry
conducted and analyzed in accordance with American Tho-
racic Society standards,11 and (4) underwent low-dose screen-
ing CT examination and physician referral for noncalcified
lung nodules. Follow-up activities (T1) were performed be-
tween March 2002 and November 2006 and included repeat
low-dose screening CT examination after 12 months and
active surveillance for lung cancer-related endpoints. This
study includes 234 subjects selected from the PLuSS cohort,
including 117 pathologically verified lung cancers and 117
control subjects, CT-screened lung cancer-free PLuSS sub-
jects individually matched to the case group according to sex
(men, women), year of birth category (before 1934, 1934–
1943, and after 1943), year of baseline CT screening exam-
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ination (2002, 2003, 2004, and 2005), cigarette smoking
status at time of PLuSS entry (current smokers and quit
within 3 years, quit for more than 3 years), and pack-year
smoking category (40.0, 40–79.9, and 80.0 pack-years).
CT Examinations
The initial or prevalence (T0) lung cancer screening
CT examinations was used for analysis in this study. The
CT examinations were performed on a GE LightSpeed Plus
4-detector (n  105) or GE LightSpeed Ultra 8-detector
(n  129) (GE Healthcare, Waukesha, WI) with the
subjects holding their breath at end inspiration. The CT
acquisition protocol was a noncontrasted, helical technique
at 120 kVp (n 45) or 140 kVp (n 189), mean 24.4 (8.3)
mAs, and a HS (GE HealthCare “High Speed”) or 1.35:1
pitch. The CT images were contiguous and reconstructed at
2.5 mm thickness using the GE’s “lung” reconstruction ker-
nel with a 512  512 pixel matrix.
CT Examination Review
Readers used lung windows/level settings (1496/-555) to
view images (2.5 mm section thickness) on a PACS monitor
display system (Stentor; Radiology Informatics Business Group
of Philips Medical Systems, Foster City, CA) and visually
assessed the presence or absence of emphysema on a four-point
scale as: (0) none, (1) trace, (2) mild, and (3) or (4) moderate-
severe. The rating scale was based on a modified NETT rating
that assigned using the percentages of emphysema: 0%,
none; 1–10%, trace; 11–25%, mild; or 26% or greater
moderate-severe.12 Details, including measures of inter-
reader reliability, appear in the online supplement to ref-
erence 1 (http://ajrccm.atsjournals.org/cgi/data/178/7/738/DC1/1).
Quantitative CT Analysis
Lung regions depicted on each CT image were seg-
mented from the surrounding chest wall and mediastinal
TABLE 1. Risk Factors, Cancer Cases vs. Matched Control Cases
Attribute
Cancers (n  117) Controlsa (n  117)
OR 95% CI pN Percentage N Percentage
Sexb
Men 61 52.1 61 52.1
Women 56 47.9 56 47.9
Age (yr)
50–59 35 29.9 37 31.6
60–69 57 48.7 56 47.9
70 25 21.4 24 20.5
Race
White 111 94.9 110 94.0
Black 6 5.1 7 6.0
Smoking statusb
Current or quit 3 yr 96 82.1 96 82.1
Quit 3 yr 21 17.9 21 17.9
Cigarette dose-duration
index (pack years)b
40 27 23.1 27 23.1
40–79 66 56.4 66 56.4
80 24 20.5 24 20.5
Family history of cancer 0.04
None or skin only 38 32.5 46 39.3 REF
Nonlung 49 41.9 56 47.9 1.05 0.59–1.85
Lung only 13 11.1 12 10.3 1.36 0.56–3.34
Lung  nonlung 17 14.5 3 2.6 6.43 1.78–23.2
Visual emphysema .0001
None 31 26.5 64 54.7 REF
Trace 28 23.9 24 20.5 2.64 1.28–5.44
Mild 40 34.2 15 12.8 6.29 2.86–13.9
Moderate-severe 18 15.4 14 12.0 3.02 1.27–7.18
Airflow obstruction 0.12
None 39 33.3 56 47.9 REF
GOLD I 20 17.1 17 14.5 1.82 0.84–3.96
GOLD II 43 36.8 34 29.1 2.03 1.04–3.93
GOLD III-IV 15 12.8 10 8.5 2.33 0.93–5.82
a Includes two subjects with lung cancer diagnosed during extended follow-up.
b Factor used to match cases and controls.
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structures using a fully automated in-house computer algo-
rithm,13 which has been improved to use three-dimensional
connectivity information. Lung voxels meeting the following
criteria were considered to be associated with the presence of
emphysema: (1) a pixel value less than 910 HU and (2) a
connection to 10 or more other pixels with a value less than
910 HU based on 2-D, 8-neighbor connectivity.14 The pres-
ence (or absence) of emphysema was quantified as the fraction
(percent) of “emphysema” voxels relative to all the lung voxels.
Airways depicted on the CT images were analyzed using an
in-house computer algorithm that automatically detects and
quantifies airway characteristics of multiple airway sections
for each CT examinations.15 The airway quantification algo-
rithm is based on a partial membership algorithm to compute
lumen area, wall area, lumen perimeter, average HU values of
the airway wall, and wall area as a percent of the total airway
area. Airway parameters were computed for all airway sec-
tions automatically detected not at or near a bifurcation and
for the smallest one third of the airway sections detected for
each subject.16 For each subject, we counted the airway
sections analyzed and computed the mean of the airway
variables across the airway sections. The airway analysis was
only performed using the detection and quantification soft-
ware without consultation from the radiologists or clinicians.
Statistical Analysis
We used conditional logistic regression to control for
matching factors and to estimate univariate lung cancer
associations with cigarette dose exposure (pack-years), fam-
ily history of cancer, visually assessed emphysema, and
spirometry results categorized according to GOLD guidelines
(At-a-Glance Pocket Reference for chronic obstructive pulmo-
nary disease (COPD) Diagnosis, Management and Prevention;
http://www.goldcopd.com/Guidelineitem.asp?l12&l21&
intId2200). For quantitative CT measures, we tabulated me-
dian and interquartile range (IQR, 25th and 75th percentile)
values and used the Kruskal-Wallis rank sum test to evaluate
group differences for statistical significance. Statistical infer-
ences used a p  0.05 two-sided significance level.
RESULTS
Subject Characteristics
As listed in Table 1, 117 lung cancer cases from the
PLuSS were well matched with 117 controls, with respect to
sex, age, race, smoking status, and pack-years. The only
differences in the groups were a higher family history of lung
cancer in the lung cancer group (p  0.04) and visual
emphysema in the lung cancer group (p  0.0001), as we
previously reported in a smaller subset of patients.1 Approx-
imately 45% of matched controls had some visual emphy-
sema and 52% had some airflow obstruction (Table 1).
Controlling for sex, year of birth, year of CT, smoking status,
and pack-years, the presence of visually assessed emphysema
associated with lung cancer more strongly than the presence
FIGURE 1. FEV1 (% predicted) versus small airway lumen
perimeter (mm) in cases and controls combined (n  234).
The rank order (Spearman) correlations between FEV1 (%
predicted) versus small airway lumen perimeter (mm) are
0.50 in the case group, 0.55 in the control group, and 0.53
in both groups combined.
TABLE 2. Airway Measures, Cancer Cases vs. Matched Control Cases
Cancers (N  117) Controlsa (N  117)
pMedian IQR Median IQR
All airways
Wall area percent, mean 53 50, 57 53 49, 56 0.24
Lumen perimeter (mm), mean 13 12, 13 13 12, 14 0.21
Lumen area (mm2), mean 13 12, 14 13 12, 16 0.24
Average airway wall HU, mean 183 204 to 160 177 200 to 157 0.24
Small airways
Wall area percent, mean 53 50 to 56 52 49 to 56 0.16
Lumen perimeter (mm), mean 10 10 to 11 10 10 to 11 0.26
Lumen area (mm2), mean 8 7 to 9 8 8 to 10 0.26
Average airway wall HU, mean 247 281 to 223 246 266 to 222 0.24
a Includes two subjects with lung cancer diagnosed during extended follow-up.
HU, Hounsfield unit; IQR, interquartile range.
Wilson et al. Journal of Thoracic Oncology • Volume 6, Number 7, July 2011
Copyright © 2011 by the International Association for the Study of Lung Cancer1202
of airflow obstruction (odds ratio: 3.59, 95% confidence
interval: 1.98–6.50, p  0.0001 versus odds ratio: 2.02, 95%
confidence interval: 1.13–3.58, p 0.02). When evaluated as
a dichotomous variable (GOLD I–IV versus none), airflow
obstruction achieved a statistically significant association
with lung cancer (p  0.02) but not when evaluated as a four
category class variable (none, GOLD I, GOLD II, GOLD
III–IV, p  0.12, Table 1).
The lung cancer case series included 102 non-small cell
lung cancers (68 prevalent and 34 nonprevalent) and 15 small
cell lung cancers (2 prevalent and 13 nonprevalent).
Table 2 lists the airway measures in cancer cases and
controls. There were no significant differences between cases
and controls in wall area %, lumen perimeter, lumen area,
average airway wall HU, as measured for all airways or for
the small airways subgroup. Figure 1 shows a correlation
between one CT airway measure (small airway lumen perim-
eter) and one spirometry variable (FEV1% predicted). As
FEV1 declines, the airway measures get smaller, as expected
(Figure 1).
Table 3 and Figure 2 show the relationship between
parenchymal measures of emphysema, the lung fraction less
than 910 HU, and visual emphysema in cases and controls.
There is no statistically significant relationship between quan-
titatively measured parenchymal measures (represented by
lung fraction910 HU) and lung cancer risk. We observed
a statistical association (p  0.0001) between visual emphy-
sema and lung fraction less than 910 HU (Figure 2). When
compared with subjects (cases and controls combined) with
less than mild emphysema, lung fraction less than 910 HU
values were higher in subjects with mild visual emphysema
and higher yet in subjects with moderate-severe visual em-
physema. Aside from perhaps slightly lower airway wall HU
values in subjects with some visual emphysema versus no
emphysema, analyses failed to identify consistent, meaning-
ful, or statistically significant association between any airway
measure and visual emphysema (Table 4).
DISCUSSION
Our matched case-control study (n  117 pairs) eval-
uated quantitative CT airway and parenchymal measures. We
also looked at airflow obstruction as measured on spirometry
and visual assessment of emphysema, as we previously pub-
lished. The relationship between airflow obstruction and lung
cancer has been the subject of numerous studies,5–7,9 which
concluded that airflow obstruction is an independent risk
factor for lung cancer. Nevertheless, none of these studies
controlled for the presence or absence of emphysema. One
study by de Torres et al.2 found that the presence of emphy-
FIGURE 2. Box plots showing lung fraction 910 HU in
cases and controls combined, subgrouped according to vi-
sual emphysema. The line segment and plus () symbol
within each box identify the median and mean, respectively.
The lower and upper borders of each box identify the 25th
and 75th percentiles, respectively. The lower whisker (lower
fence) extends to the minimum observation 25th percen-
tile minus 1.5 times the interquartile range. The upper whis-
ker (upper fence) extends to the maximum observation
75th percentile plus 1.5 times the interquartile range. No
subject had a lung fraction 910 HU measurement less
than the lower fence or greater than the upper fence.
TABLE 3. Lung Fraction 910 HU,a Cancer Cases vs. Matched Control Cases
Cancers Controlsb
pn Median IQR N Median IQR
All cases and controls 117 0.33 0.23–0.41 117 0.35 0.27–0.40 0.54
Visual emphysema
None 31 0.31 0.22–0.42 64 0.34 0.23–0.39 0.58
Trace 28 0.30 0.13–0.40 24 0.30 0.23–0.36 0.66
Mild 40 0.33 0.24–0.39 15 0.36 0.33–0.44 0.05
Moderate-severe 18 0.41 0.35–0.48 14 0.41 0.34–0.49 0.82
a Blob 10 filter.
b Includes two subjects with lung cancer diagnosed during extended follow-up.
HU, Hounsfield unit; IQR, interquartile range.
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sema on a CT scan, but not airflow obstruction, was associ-
ated with increased risk of lung cancer. Our previously
published study, as well as the current results, suggest that
emphysema by visual assessment is superior to airflow ob-
struction as a single measure of lung cancer risk.1
The quantitative analysis of low-dose screening CT
scans did not reveal any airway or parenchymal findings that
were associated with increased lung cancer risk. This finding
is similar to the results of two prior studies by the Mayo clinic
investigators.8,9 There is potential for bias in our study as 70
of 117 cancers are prevalent cancers and 34 of 70 prevalent
cancers had cancer diagnosed from the same CT scan used in
the emphysema analysis. The use of automated CT analysis
for emphysema detection in low-dose screening CT scans is
in its early stages. At trace and mild levels of emphysema by
visual assessment, our automated CT analysis shows no
difference in proportion of quantitative emphysema as mea-
sured by fraction less than 910 HU compared with the no
emphysema group (Table 3 and Figure 2). How can we
reconcile the negative findings of the automated methodology
of CT analysis for emphysema quantitation in the Mayo
studies and our current analysis with the findings of visual
emphysema as a significant predictor of increased lung cancer
risk in de Torres and our own previous studies?
One limitation is that the CT examinations were ac-
quired at a very low dose and reconstructed using an over-
enhancing, high-spatial frequency reconstruction kernel,
which create CT images with a low signal-to-noise ratio that
are not optimal for quantification of emphysema. In an effort
to adjust (correct) for the increased image noise, we imple-
mented a connectivity constraint to remove single (uncon-
nected) or small isolated “emphysema” pixels. This correc-
tion may or may not have produced results that are close to
the actual percentage of emphysema present in subjects.
Nevertheless, the CT examination for all subjects was per-
formed under essentially the same CT protocol, and, there-
fore, we believe that our quantitative emphysema measure, on
a relative scale, reproducibly ranked subjects according to CT
emphysema. Some subjects were scanned at lower x-ray tube
energy. This could theoretically affect the quantification of
emphysema, but we believe that differences in tube energy
were negligible and insignificant in terms of quantifying
emphysema.
The visual assessment of emphysema is relatively
straightforward. One looks at a CT scan and if emphysema is
present, the only debate is severity grading, which is more
subjective. The presence or absence of emphysema should be
readily discernable. We would argue that visual assessment
for the presence or absence of emphysema should be consid-
ered as the standard until the algorithms and methodology for
automated CT analysis are standardized and shown to be
reproducible on low-dose screening CT scans. The use of
quantitative methods for CT analysis is preliminary and an
evolving methodology.17
We would also suggest the possibility that quantitative
CT parenchymal analysis and visual analysis for emphysema
and quantitative CT airway analysis and FEV1 may be
measuring different things. There are validated standards for
spirometry11 and visual emphysema analysis12 that do not yet
exist for quantitative CT.
This study advances the field by enhancing the discus-
sion about the relationship of COPD, both airflow obstruction
and emphysema, and lung cancer. There seems to be differ-
ences in the relationship between emphysema and lung can-
cer using an automated quantitative volumetric analysis com-
pared with visual or semiquantitative analysis, although the
confounding results of the differing methodologies clearly
require further study and clarification. The clinical implica-
tions of this study are significant, particularly in terms of lung
cancer risk prediction in high-risk patients, and the impor-
tance of methodology in emphysema determination of screen-
ing CT scans in high-risk populations.
In conclusion, our quantitative analysis of low-dose
screening CT scans in a high-risk tobacco exposed population
failed to reproduce the association of emphysema, as assessed
visually on the same CT scans, with the diagnosis of lung
cancer. Further research into the application of quantitative
CT analysis to low-dose screening CT scans, and the rela-
tionship between emphysema, airflow obstruction, and lung
cancer is warranted.
TABLE 4. Airway Measures, According to Visual Emphysema
None (n  95) Trace (n  52) Mild (n  55)
Moderate-severe
(n  32)
pMedian IQR Median IQR Median IQR Median IQR
All airways
Wall area percent, mean 53 50 to 56 52 48 to 56 53 51 to 56 53 50 to 56 0.57
Lumen perimeter (mm), mean 13 12 to 14 12 12 to 14 13 11 to 13 12 12 to 13 0.34
Lumen area (mm2), mean 13 12 to 16 13 12 to 16 13 11 to 15 12 12 to 14 0.40
Average airway wall (HU), mean 172 192 to 153 189 218 to 166 188 204 to 167 179 208 to 260 0.03
Small airways
Wall area percent, mean 52 49 to 57 52 49 to 55 54 50 to 57 53 51 to 56 0.41
Lumen perimeter (mm), mean 10 10 to 11 10 10 to 11 10 09 to 11 10 10 to 11 0.18
Lumen area (mm2), mean 9 08 to 10 8 08 to 10 8 07 to 09 8 07 to 09 0.19
Average airway wall (HU), mean 242 265 to 207 248 280 to 228 254 275 to 225 250 284 to 289 0.13
IQR, interquartile range; HU, Hounsfield unit.
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